Association between phosphate removal and markers of bone turnover in haemodialysis patients

被引:26
|
作者
Albalate, Marta
de la Piedra, Concepcion
Fernandez, Cristina
Lefort, Mar
Santana, Henar
Hernando, Paloma
Hernandez, Jesus
Caramelo, Carlos
机构
[1] Univ Autonoma Madrid, Hosp Clin, Serv Nefrol & Bioquim, Fdn Jimenez Diaz, Madrid, Spain
[2] Univ Autonoma Madrid, Hosp Clin, Serv Epidemiol, Madrid, Spain
[3] Univ Complutense Madrid, Madrid, Spain
关键词
bone turnover; haemodialysis; osteoprotegerin; phosphate removal; PTH; RANKL;
D O I
10.1093/ndt/gfl034
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. As the main mineral reservoir, bone acts as a calcium (Ca) and phosphate buffering system. Accordingly, phosphate removal by haemodialysis (HD) might be theoretically influenced by bone turnover, as well as by the interaction of regulatory molecules, such as PTH and osteoprotegerin (OPG). The present study investigated the relationship between these variables and phosphate removal by HD. Methods. Blood samples for serum Ca, phosphate, bicarbonate, intact PTH, PTH (1 - 84), bone alkaline phosphatase, tartrate-resistant acid phosphatase 5b, OPG and receptor activator of nuclear factor-kappa B ligand ( RANKL) were obtained in 28 HD patients. Phosphate removal was measured by a continuous collection of the dialysate. Results. Pre-dialysis serum phosphate concentration is the critical factor in determining dialytic phosphate removal. However, multiple regression analysis reveals that phosphate removal is better explained by a combination of factors than by phosphate concentration alone. In this model, the PTH/OPG ratio is an additional positive factor, whereas age and vitamin D treatment are negative factors. Patients with pre-HD bicarbonate higher than 20 mEq/l had higher serum phosphate and, accordingly, higher phosphate removal; of interest, these individuals also have significant differences in RANKL/OPG. Mean (SD) OPG levels were significantly higher than that in the healthy population (16.2 ( 12.5) pmol/ l; these values correlated with age (r = 0.4, P < 0.04). Mean serum RANKL (1.03 (1.02) pmol/l) was within the range of normal individuals. Conclusions. Dialytic phosphate removal has a crucial, direct relationship with pre-HD plasma phosphate levels. However, the phenomenon of phosphate removal is more precisely explained using a more complex relationship, defined by the interaction between serum phosphate, PTH/ OPG, age and vitamin D administration. Serum RANKL levels are first reported in HD patients, and are not different from the normal population.
引用
收藏
页码:1626 / 1632
页数:7
相关论文
共 50 条
  • [1] Markers of bone turnover in haemodialysis patients
    Grzegorzewska, Alicja E.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (12) : 3602 - 3603
  • [2] Markers of bone turnover in haemodialysis patients - Reply
    Albalate, Marta
    Caramelo, Carlos
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (12) : 3604 - 3604
  • [3] Relationship between plasma levels of sclerostin, calcium–phosphate disturbances, established markers of bone turnover, and inflammation in haemodialysis patients
    Barbara Pietrzyk
    Katarzyna Wyskida
    Joanna Ficek
    Aureliusz Kolonko
    Rafał Ficek
    Andrzej Więcek
    Magdalena Olszanecka-Glinianowicz
    Jerzy Chudek
    International Urology and Nephrology, 2019, 51 : 519 - 526
  • [4] RELATIONSHIP BETWEEN PLASMA LEVELS OF SCLEROSTIN AND MARKERS OF BONE TURNOVER IN HAEMODIALYSIS PATIENTS WITH CKD
    Pietrzyk, Barbara
    Wyskida, Katarzyna
    Wajda, Jaroslaw
    Klein, Dariusz
    Witkowicz, Joanna
    Ficek, Rafal
    Rotkegel, Sylwia
    Spiechowicz-Zaton, Urszula
    Kocemba-Dyczek, Joanna
    Ciepal, Jaroslaw
    Wiecek, Andrzej
    Olszanecka-Glinianowicz, Magdalena
    Chudek, Jerzy
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [5] Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients
    Fournier, A
    Ghitu, S
    Bako, G
    Ben Amar, L
    Oprisiu, R
    Hottelart, C
    Solal, MEC
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (11) : 2772 - 2773
  • [6] Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients
    Coen, G
    Ballanti, P
    Bonucci, E
    Calabria, S
    Centorrino, M
    Fassino, V
    Manni, M
    Mantella, D
    Mazzaferro, S
    Napoletano, I
    Sardella, D
    Taggi, F
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (09) : 2294 - 2302
  • [7] Relationship between plasma levels of sclerostin, calcium-phosphate disturbances, established markers of bone turnover, and inflammation in haemodialysis patients
    Pietrzyk, Barbara
    Wyskida, Katarzyna
    Ficek, Joanna
    Kolonko, Aureliusz
    Ficek, Rafal
    Wiecek, Andrzej
    Olszanecka-Glinianowicz, Magdalena
    Chudek, Jerzy
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (03) : 519 - 526
  • [8] Effect of haemodialysis on markers of bone turnover in children
    Waller, Simon
    Ridout, Deborah
    Rees, Lesley
    PEDIATRIC NEPHROLOGY, 2007, 22 (04) : 586 - 592
  • [9] Effect of haemodialysis on markers of bone turnover in children
    Simon Waller
    Deborah Ridout
    Lesley Rees
    Pediatric Nephrology, 2007, 22 : 586 - 592
  • [10] Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients - Reply
    Coen, G
    Ballanti, P
    Bonucci, E
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (11) : 2773 - 2774